Form D · Private Equity Fund
Hamilton Square Biotech Partners (Offshore), LP
Princeton, NJ · CIK 0002069766
Offering snapshot reported Nov 13, 2025 · SEC filing
- Reported sold
- $4.47M Indefinite offering
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 14, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 2
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 13, 2025 | Amendment | $4,472,500 | No comparison | 2 | SEC filing |
| Jun 3, 2025 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-547928
Source: Form D, filed Nov 13, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Hamilton Square Biotech Partners Gp, Llc | Executive |
| Hamilton Square Partners Management, Lp | Executive |
| David Tukey | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
300 Carnegie Center Suite 150
Princeton, NJ, 08540
Princeton, NJ, 08540